THE INVESTOR

메뉴열기
August 15, 2018

Korea bans sale of 59 drugs used to treat high BP

PUBLISHED : August 06, 2018 - 13:32

UPDATED : August 06, 2018 - 13:32

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • 트위터
  • sms


[THE INVESTOR] Korea’s drug safety watchdog said Monday that it has banned Daebong LS, a local maker of valsartan, from selling and making the active ingredient meant to treat high blood pressure over a cancer-causing substance in the drug.

The Ministry of Food and Drug Safety has also prohibited 22 Korean pharmaceutical firms from selling 59 products made by Daebong LS that contain valsartan.

The move came as some of the valsartan made by Daebong LS has been confirmed to have an impurity known as N-nitrosodimethylamine (NDMA).

NDMA is classified as a probable human carcinogen by the World Health Organization’s International Agency for Research on Cancer.

Daebong LS makes the active ingredient valsartan after importing crude valsartan from China’s Zhuhai Rundu Mintong Pharmaceutical.

By Song Seung-hyun and newswires (ssh@heraldcorp.com)

  • 페이스북
  • 트위터
  • sms
최상단으로
Herald Corporation|CEO : Kwon Chung Won
Chief Privacy Officer & Juvenile Protection Manager : Shin Chang Hoon
Company Registration No. 104-81-06004
Mail-Order Business Registration 2016 - Seoul Yongsan - 00590
Huam-ro 4-gil 10, Yongsan-gu, Seoul, Korea
T : +82-2-727-0615|Business info
COPYRIGHT HERALD CORPORATION. ALL RIGHTS RESERVED.